Home Newsfeeds Former Soviet Leader Mikhail Gorbachev Dies

News

Former Soviet Leader Mikhail Gorbachev Dies

– Interfax News Agency

byBenzinga Newsdesk

August 30, 2022

1 minute read

– Interfax News Agency

News

Worldwide Clinical Trials Enters Into Collaboration With Invitae To Accelerate Clinical Trials For Rare Disease Patients

By Bill Haddad

July 12, 8:20 AM

CRO gains access to genetic testing data, aims to improve global research with enhanced data insights and faster patient recruitment for rare disease studies Worldwide Clinical Trials, Inc. (Worldwide), the

NVTA

B. Riley Securities Maintains Buy on Altimmune, Raises Price Target to $26

By Benzinga Newsdesk

August 12, 9:55 AM

B. Riley Securities analyst Mayank Mamtani maintains Altimmune (NASDAQ:ALT) with a Buy and raises the price target from $21 to $26.

ALT

SEC Adopts Rule To Increase Transparency Into Short Selling and Amendment To CAT NMS Plan For Purposes Of Short Sale Data Collection

By Benzinga Newsdesk

October 13, 12:38 PM

https://www.sec.gov/news/press-release/2023-221 SEC Adopts Rule to Increase Transparency Into Short Selling and Amendment to CAT NMS Plan for Purposes of Short Sale Data CollectionWashington, D.C.--(Newsfile Corp. -

SPY

‘FYARRO, Sirolimus Protein-Bound Particles For Injectable Suspension, Albumin-Bound, FDA Approved For Treatment Of Locally Advanced Unresectable Or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available At Biologics By McKesson’

By Benzinga Newsdesk

December 22, 11:19 AM

https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2022/FYARRO-FDA-Approved-Treatment-Advanced-Unresectable-Metastatic-Malignant-Perivascular-Epithelioid-Cell-Tumor/ Biologics by McKesson, an independent

MCK

Former Soviet Leader Mikhail Gorbachev Dies

Related Posts

Worldwide Clinical Trials Enters Into Collaboration With Invitae To Accelerate Clinical Trials For Rare Disease Patients

B. Riley Securities Maintains Buy on Altimmune, Raises Price Target to $26

SEC Adopts Rule To Increase Transparency Into Short Selling and Amendment To CAT NMS Plan For Purposes Of Short Sale Data Collection

‘FYARRO, Sirolimus Protein-Bound Particles For Injectable Suspension, Albumin-Bound, FDA Approved For Treatment Of Locally Advanced Unresectable Or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available At Biologics By McKesson’